Premium
Improved performance of first‐trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks
Author(s) -
Kirkegaard Ida,
Petersen Olav Bjørn,
Uldbjerg Niels,
Tørring Niels
Publication year - 2008
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.2057
Subject(s) - trisomy , medicine , significant difference , gestational age , nuchal translucency , gestation , obstetrics , false positive rate , pregnancy , down syndrome , gynecology , first trimester , pediatrics , biology , psychiatry , statistics , genetics , mathematics
Objective To evaluate if there is a performance difference in the combined screening for trisomy 21 between the double tests performed before and after 10 + 0 weeks of gestation. Methods The study included all 97 trisomy 21 cases from January 2004 to December 2007, in a screening program where the double test was measured in week 8 + 0 to 13 + 6 and the nuchal translucency in week 11 + 3 to 13 + 6. Results As many as 87 of the 97 cases were diagnosed in the screening program (detection rate = 90%). Among the 53 cases having the double test taken before 10 + 0 weeks, no cases were missed [detection rate (DR) = 100%, CI = 0.94–1.00] and among the 44 having the double test taken after 10 + 0 weeks, 10 cases were missed (DR = 77%, CI = 0.65–0.90). This difference in DR was highly significant ( P = 0.0009). No difference was observed between false positive rates or median maternal age of the two groups. Conclusion A significantly higher DR was obtained when the double test was taken early in pregnancy (<10 + 0 weeks), than when it was taken later (≥10 + 0 weeks). The results could not be explained by a difference in either the false positive rate or the maternal age between the two groups. Copyright © 2008 John Wiley & Sons, Ltd.